Related Experiment Video

Updated: Jul 25, 2025

A Modified EPA Method 1623 that Uses Tangential Flow Hollow-fiber Ultrafiltration and Heat Dissociation Steps to Detect Waterborne Cryptosporidium and Giardia spp.
12:11

A Modified EPA Method 1623 that Uses Tangential Flow Hollow-fiber Ultrafiltration and Heat Dissociation Steps to Detect Waterborne Cryptosporidium and Giardia spp.

Published on: July 9, 2012

20.5K

Ultrastructural Alterations of the Human Pathogen Giardia intestinalis after Drug Treatment

Marlene Benchimol1,2,3, Ana Paula Gadelha4, Wanderley de Souza2,3

  • 1BIOTRANS-CAXIAS, Universidade do Grande Rio. UNIGRANRIO, Rio de Janeiro 96200-000, Brazil.

Pathogens (Basel, Switzerland)
|June 28, 2023
PubMed

Insights

This review examines how common drugs affect Giardia intestinalis cells. It highlights the need for new treatments due to drug resistance and side effects, focusing on novel strategies targeting parasite adhesion.

Area of Science:

  • Parasitology
  • Pharmacology
  • Infectious Diseases

Background:

  • Giardia intestinalis is a significant intestinal parasite causing diarrhea, particularly in children.
  • Current treatments like metronidazole and albendazole face challenges including side effects and emerging drug resistance.
  • Benzimidazole carbamates show in vitro efficacy, but clinical outcomes are inconsistent, necessitating alternative therapies.

Purpose of the Study:

  • To review cellular alterations in Giardia intestinalis upon incubation with existing antigiardial drugs.
  • To discuss the limitations of current therapies and explore novel drug targets and strategies.
  • To provide insights for developing more effective chemotherapy against Giardiasis.

Main Methods:

  • In vitro incubation of Giardia intestinalis with commercial antigiardial drugs.
  • Analysis of altered cell characteristics, including structural and metabolic pathways.
  • Review of existing literature on drug efficacy, resistance, and emerging therapeutic approaches.

Main Results:

  • Metronidazole and albendazole, common treatments, induce specific cellular changes in Giardia.
  • Resistance to metronidazole is a growing concern, impacting treatment effectiveness.
  • Benzimidazoles exhibit potent in vitro activity, yet clinical efficacy is variable.

Conclusions:

  • There is a critical need for novel therapeutic agents against Giardia intestinalis due to resistance and side effects of current drugs.
  • Targeting unique parasite structures like the ventral disc, essential for adhesion, presents a promising avenue for new drug development.
  • Further research into alternative compounds and therapeutic strategies is essential for improved Giardiasis treatment.
Keywords:
Giardia treatmentchildren’s diseasediarrheaintestinal parasite

More Related Videos

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment12:58

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

Published on: May 25, 2017

9.1K
Quantitative Polymerase Chain Reaction-based Analyses of Murine Intestinal Microbiota After Oral Antibiotic Treatment08:33

Quantitative Polymerase Chain Reaction-based Analyses of Murine Intestinal Microbiota After Oral Antibiotic Treatment

Published on: November 17, 2018

13.1K

Related Concept Videos

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
163
Drug Absorption: Factors Affecting GI Absorption01:19

Drug Absorption: Factors Affecting GI Absorption

The process of oral drug absorption can be influenced by several factors. Weakly acidic drugs tend to be absorbed more readily from the stomach due to their nonionized state. However, absorption may be less efficient in the upper intestine, where drugs are often ionized. Interestingly, despite the stomach's apparent advantage for drug absorption, its mucous layer can hinder diffusion. Its surface area is also smaller than the intestine's, which can further slow down the absorption rate.
4.1K
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
218
Factors Influencing Drug Absorption: Disease States and Pharmacology01:25

Factors Influencing Drug Absorption: Disease States and Pharmacology

Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
593
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents01:20

Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents

Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
256
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
179